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longer, 42 amino acid species (A42) have received
greater attention due to the propensity of these peptidesA large body of evidence has implicated A peptides
to nucleate and drive production of amyloid fibrils (Jar-and other derivatives of the amyloid precursor protein
rett et al., 1993).(APP) as central to the pathogenesis of Alzheimer’s
Recent lines of experimental evidence have sug-disease (AD). However, the functional relationship of
gested that excessive amounts of A are deleterious toAPP and its proteolytic derivatives to neuronal electro-
neuronal function, in addition to, or in lieu of, its pro-physiology is not known. Here, we show that neuronal
posed neurotoxic effects. First, addition of A in variousactivity modulates the formation and secretion of A
aggregation states to neuronal preparations has beenpeptides in hippocampal slice neurons that overex-
shown to elicit electrophysiological phenotypes (Cullen
press APP. In turn, A selectively depresses excitatory
et al., 1997; Freir et al., 2001; Hartley et al., 1999; Kim
synaptic transmission onto neurons that overexpress et al., 2001; Stephan et al., 2001). However, these studies
APP, as well as nearby neurons that do not. This depres- have been challenged because of the difficulties in work-
sion depends on NMDA-R activity and can be reversed ing with the peptides, whose biological properties can
by blockade of neuronal activity. Synaptic depression depend on aggregation states and peptide size and
from excessive A could contribute to cognitive de- composition (Fezoui et al., 2000; Walsh et al., 1999).
cline during early AD. In addition, we propose that Furthermore, the relevant subcellular sites and (patho)-
activity-dependent modulation of endogenous Apro- physiological concentrations are not known and thus
duction may normally participate in a negative feed- difficult to mimic by exogenous application. Alternative
back that could keep neuronal hyperactivity in check. approaches using transgenic mouse models expressing
Disruption of this feedback system could contribute various naturally occurring familial AD-linked mutants
to disease progression in AD. of APP have also yielded valuable insights into the physi-
ological and behavioral consequences of excessive A
Introduction production and accumulation (Chapman et al., 1999;
Fitzjohn et al., 2001; Hsia et al., 1999; Larson et al., 1999;
Alzheimer’s disease (AD), the most common form of Westerman et al., 2002). However, the interpretations
dementia in the elderly, is a progressive neurodegenera- of these studies are complicated by the fact that the
transgenes are expressed at high levels throughout de-
velopment and aging. Furthermore, several domains*Correspondence: malinow@cshl.org
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Figure 1. Neural Activity Controls Formation
of APP Cleavage Derivatives
(A) Biochemical pathways leading to the for-
mation of A from APP.  and  cleavage of
APP result in the production of a large, solu-
ble ectodomain (APPs) and a membrane-
associated carboxy-terminal fragment (CTF).
Cleavage of APP by -secretase precludes
production of A. -secretase cleavage of
CTFs produce small peptides (A and p3)
which can be secreted and a truncated CTF
(-CTF).
(B) Organotypic hippocampal slices prepared
from mice expressing human APPSwe were
maintained in culture with indicated drugs (te-
trodoxin [TTX], 1 M; 10 mM MgCl2; picro-
toxin [PTX], 100 M; flunitrazepam [Flu], 1
M). Media aliquots were collected and ana-
lyzed for A40 and A42. Values expressed
as percentage of secretion seen in sister
slices maintained in control media. All values
different from control, p  0.05.
(C) Rat organotypic slices were infected (APP
WT, APP WT  TTX, APP WT  Mg) or not
infected (Uninf) and maintained in culture me-
dia (Uninf, APP WT), in culture media with 1
uM TTX (APP WT  TTX), or in culture media
with 10 mM MgCl (APP WT  Mg) for 24 hr
(n  3 for each). Superfusate media was col-
lected and analyzed for A40 or A42 as
above.
(D) Western blots of extracts from organo-
typic APPSWE slices in the presence of -secre-
tase inhibitor 1M L-685,458 (to prevent deg-
radation of  secretase products and
therefore aiding fragment detection) treated
with (n  8) or without (n  8) picrotoxin (100
M) and 8 mM CaCl2 for 36 hr. Blots were
probed with an antibody specific for 1
BACE cleavage site (3D6) and subsequently
reprobed using CT-15 for detection of full-
length APP. Bands corresponding to the
BACE APP cleavage product and full-length
APP were quantified by scanning.
(E) Western blots of extracts form organotypic APPSWE slices in the presence of L-685,458 and treated with (n  3) or without (n  3) TTX for
36 hr as in (D). Note that levels of full-length APP are not significantly changed by either blocking or enhancing neuronal activity (control:
1.0  0.13, TTX: 1.0  0.04, p  0.9; control: 1.0  0.11, PTX/Ca2: 1.2  0.15, p  0.3).
(F) IP-Western blot of culture media from organotypic APPSWE slices treated for 36 hr with 1 m TTX (n  8), picrotoxin (100 mm) and 8 mM
CaCl2 (n  8), or untreated (n  8). APPSWEs was precipitated from culture media using antibody 54, which specifically recognizes the C
terminus of APPSWEs, and subsequently blotted with the antibody 22C11, which recognizes the N terminus domain of APP. 1 m L-685,458
was present in all samples to parallel (D) and (E) above.
within APP have been described that may have impor- overexpression on synaptic transmission, and the ef-
fects of synaptic transmission on APP processing.tant physiological functions (Cao and Sudhof, 2001;
Kamal et al., 2001), and thus, the consequence of over- The regulatory mechanisms that control A biosyn-
thesis have received much interest, as these are attrac-expressing APP may have unanticipated effects on
physiological and behavioral measures of learning and tive targets for therapeutic intervention. While a number
of proteins have been identified whose expression ap-memory. We thus sought to develop a system where
the physiologic effects of acute APP overexpression pear to influence Aproduction (Sabo et al., 2001; Sastre
et al., 1998; Yu et al., 2000), there is little informationcould be ascertained and in which the relevant molecu-
lar determinants could be dissected. We employed the about the neuronal mechanisms that modulate A pro-
duction. Here, we show that neuronal activity regulatesSindbis expression system (Hayashi et al., 2000; Schle-
singer and Dubensky, 1999; Shi et al., 1999; Zhu et al., the production and secretion of A by controlling APP
processing upstream of -secretase activity. In addition,2000) to acutely deliver APP and APP-related constructs
in organotypic hippocampal slices over a period of be- we report that A modulates synaptic strength. Taken
together, these two observations suggest a negativetween 12 and 72 hr (Stoppini et al., 1991). In this experi-
mental setting, we could determine the effects of APP feedback role for A, which can be revealed by inhibition
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of -secretase activity. Thus, A may play a role in nor- or if neuronal activity affects the accessibility of APP to
BACE activity.mal synaptic physiology, as well as in pathological pro-
cesses leading to AD. To test if acutely overexpressed APP is under similar
regulation, we used a Sindbis expression system to de-
liver APP to rat organotypic slice neurons. Media fromResults
slices expressing recombinant APP for 24 hr released
more A (both A40 and A42) into the medium com-Neuronal Activity Controls Formation
pared to uninfected slices. This secretion could be re-and Secretion of A
duced by inhibiting neuronal activity during the incuba-To examine A secretion in neuronal tissue, we mea-
tion period with TTX or high Mg2 (Figure 1C), indicatingsured (Suzuki et al., 1994) A in the media collected
that production and secretion of A from neurons thatfrom organotypic hippocampal slices prepared from
acutely overexpress APP is under similar activity-transgenic (tg) mice (Borchelt et al., 1997) expressing the
dependent regulation as that seen in neurons that ex-Swedish APP mutation (APPSWE). This mutation causes
press transgene-derived APPSWE. Lastly, we also foundautosomal dominant familial AD in two Swedish pedi-
that the low-level secretion of endogenous A from ratgrees and has been shown to enhance production of
organotypic slices could also be reduced by incubationApeptides (Citron et al., 1992). To determine the effects
with TTX for 24 hr (A40: control: 410.5  36.4 pM [n of neuronal activity on A secretion, slices were main-
4], TTX: 274.0 27.3 pM [n 3], p 0.03; A42: control:tained in the presence of pharmacological agents that
39.4  2.4 pM [n  4], TTX: 25.8  3.3 pM [n  3],either decrease (tetrodotoxin, high magnesium, or fluni-
p  0.03), suggesting that endogenous A secretiontrazepam [a GABA-A receptor potentiator]) or increase
operates under a similar regulatory mechanism.(picrotoxin [a GABA-A channel blocker]) neuronal activ-
ity. Agents that decreased or increased activity resulted
in significant reductions or elevations, respectively, in APP Overexpression Depresses
Synaptic Transmissionlevels of A (both A40 and A42) detected in the me-
dium (Figure 1B). These results indicate that the secre- To address whether APP can control synaptic function,
we overexpressed APP or various APP mutants in wild-tion of A from neuronal cells that chronically overex-
press APP can be controlled by neuronal activity. type rat hippocampal slice neurons using the Sindbis
expression system. For these experiments, neuronsWe next wished to evaluate if neuronal activity regu-
lates A secretion by controlling- or -secretase cleav- were sparsely infected. Infected neurons were identified
by coexpressing (cytoplasmic) diffusable GFP (see Ex-age. These two possibilities can be distinguished by
examining the level of -CTF, the membrane-tethered perimental Procedures). One day after infection, the re-
combinant APP distributed homogenously throughoutfragment of APP generated by the action of -secretase
(BACE), that is also a substrate for -secretase (Figure the dendritic tree including dendritic spines (the sites
of excitatory contacts), with no obvious effects on den-1A). We reasoned that if neuronal activity enhances only
-secretase cleavage, then -CTF levels should de- dritic morphology (Figure 2A). We tested the effects of
APP overexpression on synaptic transmission by com-crease. On the other hand, if -secretase cleavage alone
is enhanced by neuronal activity, then -CTF levels paring synaptic responses evoked onto side-by-side
pairs of simultaneously recorded postsynaptic neuronsshould increase. Lastly, if both - and-secretase activi-
ties are enhanced by increased neuronal activity, then where only one neuron expresses the exogenous pro-
tein. Excitatory synaptic responses onto neurons ex--CTF levels should not change significantly. To address
this issue, we conducted Western blot analysis on ly- pressing recombinant APP were significantly depressed
one day after expression, while inhibitory (GABA) cur-sates of organotypic slices prepared from APPSWE tg
mice. We probed blots with an antibody raised against rents were unaffected (Figure 2B) (see Experimental
Procedures for details of response isolation and mea-the carboxy-terminal 15 amino acids of APP that recog-
nizes full-length APP (CT-15), or an antibody that specifi- surement). No such depression occurred onto cells ex-
pressing only GFP (AMPA: control: 100%  7.0%, in-cally recognizes the amino terminus of -CTF (3D6).
As shown in Figure 1D, increasing neuronal activity by fected: 96%  6.1%, n  52, p  0.3; NMDA: control:
100%  9.5%, infected: 90  10.4, n  52, p  0.2incubating slices in picrotoxin and elevated Ca2 signifi-
cantly enhanced the levels of -CTF. Furthermore, de- [Hayashi et al., 2000]). Neurons expressing APP showed
significant decrease in the frequency of miniaturecreasing neuronal activity by incubating slices in TTX
significantly decreased levels of -CTF (Figure 1E). In EPSCs, with no change in their amplitude (Figure 2C)
nor in paired-pulse facilitation (Figure 2D). These resultsaddition, we examined the effects of neuronal activity
on the levels of secreted APPs, which should parallel suggest that the depressive effects of APP overexpres-
sion are due to a decrease in the number of functionalthe changes in -CTF, if APP processing is altered. As
expected, incubating slices in TTX reduced the amount synapses. This could be due to pre- and/or postsynaptic
modification(s).of APPs released into the culture medium. The levels
of APPs were not increased by incubating slices in PTX To determine if BACE processing of recombinant APP
is required for the depressive effects of APP overexpres-and high Ca2, suggesting that activity may also affect
degradation of APPs. Together, these results suggest sion, we expressed a mutant form of APP, APPMV (Citron
et al., 1995), which shows little cleavage by BACE atthat the level of BACE cleavage can be controlled by
neuronal activity. Our experiments, however, do not es- the 1 position of A (cleavage at this site is required
to generate A40 or A42). Expression of this mutanttablish if neuronal activity affects intrinsic BACE activity,
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Figure 2. APP Overexpression Depresses
Excitatory Synaptic Transmission: Require-
ments for APP Processing
(A) Two-photon laser scanning microscopic
image of organotypic hippocampal slice neu-
rons infected with Sindbis virus expressing
APP(myc)-IRES-GFP. Slices were fixed, per-
meabilized, and immunostained for myc. Left,
GFP fluorescence; right, anti-myc fluores-
cence. Scale bars, 10 m. Note dendritic
spines in lower panels contain recombinant
APP.
(B) Graph of AMPA (n  29), NMDA (n  25),
and GABA (n  44) components of synaptic
transmission measured in pairs of neurons
noninfected (filled bars) and infected (open
bars) with virus expressing wild-type APP. In-
set: sample traces of AMPA (top), NMDA
(middle), and GABA (bottom) responses in
noninfected and infected (arrow) cells. Scale
bars for this and subsequent evoked whole-
cell traces: 20 pA, 20 ms.
(C) Miniature EPSC responses recorded in
whole-cell mode from neurons in organotypic
slices that did not (control, n  12) or did
express APP (n  10). Frequency of events
was diminished (control: 0.27  0.05 Hz, in-
fected: 0.17  0.02 Hz), with no change in
their mean amplitude (control: 13.2  0.9 pA,
infected: 11.6  0.7 pA) by APP expression.
Right, sample traces for each condition (scale
bars: 5 pA, 100 ms).
(D) Paired-pulse faciliation evoked onto non-
infected (top) and infected (bottom) neurons.
Bar graph shows averages from n  20 cells.
(E) Same graph as (B) for neurons expressing
APPMV (AMPA, n  59; NMDA, n  45).
(F) Same graph as (B) for transmission re-
corded from neurons expressing wild-type APP
and maintained in the -secretase inhibitor
L-685,458 (AMPA , n  29; NMDA, n  29).
(G) Western blot of hippocampal extracts
from slices infected and treated as indicated
above. Blots were probed with anti-APP car-
boxy-terminal antibody, CT-15 (Sisodia et al.,
1993).
produced no significant depression of transmission (Fig- nearby control cells (Figure 2F). Parallel experiments
showed that slices expressing APP in the presenceure 2E); the effect on transmission by APPMV was signifi-
cantly different from the effect of wild-type APP (AMPA: of L-685,458 displayed the expected accumulation of
-CTF and-CTF, the immediate substrates for -secre-p  0.014 [n  55, 63]; NMDA: p  0.015 [n  50,
49], K-S test). Parallel experiments showed that slices tase (Figure 2G). These studies indicate that APP synthe-
sis and proteolytic steps prior to -secretase cleavageinfected with this virus express APPMV, and as expected,
the APP-CTF product that would be generated by pro- were not impaired by the addition of L-685,458. Further,
these results indicate that -secretase processing ofcessing by BACE at 1 site is not apparent (Figure 2G).
This result indicates that BACE cleavage at the 1 site APP is required for the depressive effects of APP and
that this phenotype is independent of the formation ofis necessary for the depressive effects of APP overex-
pression on transmission. Furthermore, these results the large ectodomain of APP following either  or 
cleavage events (Furukawa et al., 1996).indicate that -secretase-generated -CTF is unlikely
to be responsible for the depressive effects, since this
product is still generated from APPMV (Figure 2G). A Production from APP Mediates Depression
of TransmissionTo assess the requirement for -secretase processing
of APP on the depressive effect on synaptic transmis- The requirement for BACE and -secretase processing
of recombinant APP strongly suggests that Amediatession, we employed a highly potent and selective-secre-
tase inhibitor, L-685,458 (Li et al., 2000). Slices were the observed phenotype on neuronal transmission. On
the other hand, another carboxy-terminal derivative ofinfected with a virus producing APP and maintained in
the presence of L-685,458 for 24 hr. Transmission onto APP, termed -CTF, or AICD (see Figure 1A) has been
described that may serve as a transcriptional coactiva-neurons expressing APP was not depressed relative to
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Figure 3. A Domain of APP Is Necessary
and Sufficient to Depress Synaptic Trans-
mission
(A) Schematic diagram of APP constructs
used in this figure. SP indicates signal
peptide.
(B) Graph of AMPA (n  33) and NMDA (n 
31) components of synaptic transmission
measured in pairs of neurons noninfected
(filled bars) and infected (open bars) with virus
expressing -CTF. Inset: sample traces of
transmission measured at 	60mV (left)
and40mV (right) from noninfected (top) and
infected (bottom) neurons.
(C) Same as (B) but slices incubated in the
presence of L-685,458 (AMPA, n 40; NMDA,
n  33).
(D) Western blot of hippocampal extracts
from slices infected with APPMV in the ab-
sence (left) or presence (right) of -secretase
inhibitor L-685,458. Blots were probed with
CT-15 (see Experimental Procedures and Fig-
ure 1).
(E) Same as (B) for neurons expressing
-CTF(KKKQ) (AMPA, n 40; NMDA, n 32).
(F) Same as (B) for neurons expressing
APLP2/APP Chimera (AMPA, n  35; NMDA,
n  33).
tor (Cao and Sudhof, 2001). However, -CTF accumu- membrane domain, and a KKKQ membrane-anchoring
motif, but lacks the intracellular C terminus, was ablelates in cells treated with L-685,458 (Figure 3D), indicat-
ing that this APP derivative is a substrate of -secretase, to produce a depression of synaptic transmission (Fig-
ure 3E), although not to the extent produced by expres-and thus likely a precursor of -CTF. Taken together
with the finding that abundant amounts of -CTF are sion of -CTF (Figure 3B). The reduced depression by
-CTFKKKQ may be due to inefficient trafficking of thisproduced in APPMV-infected cells (Figure 2G), which
show no synaptic depression (Figure 2E), we feel it un- polypeptide to sites of action, since cellular targeting
of APP is largely controlled by the APP C terminus (Perezlikely that-CTF is responsible for the depressive effects
on synaptic transmission. et al., 1999). In any event, these results argue that the
A domain is sufficient to depress transmission. As aTo test more directly whether A is necessary and
sufficient to produce a depression of synaptic transmis- further test that A is necessary for depression of synap-
tic transmission, we generated a chimeric -CTF con-sion, we infected hippocampal slice neurons with
Sindbis virus harboring cDNA encoding -CTF, a poly- struct in which the A region was replaced by the corre-
sponding region in APLP2, an APP homolog that haspeptide that includes A, and the entire transmembrane
and cytoplasmic domains of APP (Figure 3A) [Iwata et considerable homology with APP throughout most of
its length except in the A region, where there is consid-al., 2001]). As expected, expression of -CTF was suffi-
cient to depress synaptic transmission (Figure 3B), and erable divergence (Wasco et al., 1993) (see Figure 3A).
Expression of this APLP2/APP chimera did not depressthis depression was prevented by incubating slices in
the -secretase inhibitor L-685,458 (Figure 3C). Indeed, synaptic transmission (Figure 3F), further supporting the
view that the A domain of APP is crucial for the ob-expression of a truncated -CTF (-CTFKKKQ [Iwata et
al., 2001]; Figure 3A) that contains A, the entire trans- served synaptic depression. Taken together, these re-
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Figure 4. Synaptic Depression Mediated by
APP Overexpression Is Activity Dependent
and Reversible
(A) Amplitude of AMPA-mediated synaptic
transmission recorded in neurons expressing
APP WT for 24 or 48 hr (n  27). Slices were
maintained in normal medium (black), in TTX
for hours 0–24 (red, n 23), or in TTX for hours
24–48 (blue, n  37). * indicates significant
difference from value obtained at same time
point in different conditions. Inset: sample
traces of transmission measured at 	60mV
for each of the time points.
(B) Graph of AMPA (n  33) and NMDA (n 
32) components of synaptic transmission
measured in pairs of neurons noninfected
(filled bars) and infected (open bars) with virus
expressing APP WT incubated in the pres-
ence of 100 uM D,L AP5. Inset: sample traces
of transmission measured at 	60mV (left)
and40mV (right) from noninfected (top) and
infected (bottom) neurons.
(C) Same as (B) for neurons expressing -CTF
and maintained in TTX (AMPA, n 36; NMDA,
n  32).
sults indicate that the A domain is necessary and suffi- period also blocked APP-induced depression (AMPA:
control: 100%  11.3%, infected: 100%  12%, n  28,cient for APP overexpression to produce synaptic
depression. p 0.7; NMDA: control: 100% 10.7%, infected: 90%
9.7%, n 27, p 0.3). We next tested whether synaptic
NMDA receptor activation could prevent synaptic de-APP-Induced Depression Requires
Neuronal Activity pression produced by APP overexpression. Slices were
incubated with 100 M D,L AP5, an agent that blocksThe results shown above indicate that processing of
APP into A is dependent on neuronal activity and that NMDA-Rs and has previously been shown not to affect
spontaneous neuronal activity (Zhu et al., 2000). Notably,formation of A results in synaptic depression. Thus, a
direct prediction of these findings is that blockade of blockade of NMDA receptors prevented the depression
caused by APP overexpression (Figure 4B). Thus, it ap-neuronal activity should prevent the depressive actions
of APP overexpression. To test this prediction, we main- pears that NMDA receptor activation by spontaneous
neuronal activity is required for APP overexpression totained slices in conditions where spontaneous neuronal
activity was blocked during the expression of full-length depress synaptic transmission.
Our results above suggest that neural activity affectsAPP and subsequently assayed the effects on physiol-
ogy. AMPA-mediated synaptic transmission onto neu- A production by controlling BACE cleavage of APP.
Another prediction from this finding is that blockade ofrons that express recombinant APP and maintained in
TTX showed no depression of synaptic transmission neural activity should not prevent the synaptic depres-
sion produced by expression of -CTF. Indeed, whilecompared to neurons expressing recombinant APP and
maintained in normal medium (Figure 4A; 24 hr with or the -secretase inhibitor did block synaptic depression
by -CTF (Figure 3C), TTX did not (Figure 4C). Takenwithout TTX, p  0.006, K-S test). Similar results were
obtained by measuring NMDA responses (data not together, these results provide physiological and bio-
chemical support for the notion that neuronal activityshown). It is notable that in conditions where neuronal
activity is suppressed, APP-overexpressing neurons promotes production of A by modulating BACE pro-
cessing of APP.demonstrate normal synaptic transmission, near base-
line levels of A42, but still significant (albeit reduced)
levels of A40 (Figure 1C). This suggests that A42, Depressive Effects of A Are Reversible
To determine if the depressive effects on transmissionrather than A40, may more potently contribute to the
observed synaptic depression. by APP overexpression are reversible, we initially placed
slices overexpressing APP in normal culture media forWe tested the generality of this activity-dependent
effect by using other agents known to suppress neuronal 24 hr; TTX was then added to fresh media for 24 hr,
and synaptic transmission was subsequently assayed.activity. Indeed, 10 M NBQX (an AMPA receptor antag-
onist) added to the culture media during the incubation Remarkably, after such a protocol, synaptic responses
APP Processing and Synaptic Function
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Figure 5. Secreted A Can Depress Trans-
mission onto Nearby Neurons
(A) Schematic of experimental paradigm. Un-
infected neuron is surrounded by infected
neurons in region a; uninfected neuron is sur-
rounded by uninfected neurons in region b.
Either cell a or cell b was assigned coordi-
nates (0,0) for simplicity; s indicates coordi-
nates of stimulating electrode.
(B) Fluorescent (left) and DIC (right) images
of a small region within the CA1 infected with
a high titer APP virus. Arrow indicates an un-
infected cell surrounded by many infected
cells.
(C) Comparison of AMPA transmission be-
tween simultaneously recorded pairs of unin-
fected neurons in the two different regions.
Cumulative distributions were computed us-
ing the ratio of the amplitude response of a
neuron in region a to the amplitude response
of a neuron in region b. Separate distributions
were computed for APPSWE and APPMV. Ampli-
tude response ratios are reported in a log scale
for display purposes. Inset: sample traces of
AMPA transmission for a pair of uninfected
neurons, one neuron surrounded by APP SWE-
expressing neurons (left), or APP MV-express-
ing neurons (right).
(D) Same as (C) for NMDA transmission.
(E) Field recordings of evoked EPSPs moni-
tored from acute rat slices exposed to varying
amounts of A peptides. After obtaining sta-
ble baseline responses for 20 min, freshly dis-
solved A peptides (1 m A40  0.05 m
A42 or 10 m A40  0.5 m A42) were
added to the circulating ACSF, and re-
sponses were monitored for the next 40 min.
in infected cells recovered to control levels (Figure 4A). the amount of A reaching a control neuron is likely to
be orders of magnitude lower than the amount secretedExpression of APP for 2 days with no TTX treatment
by the infected neuron (the expression protocol wasshowed no such recovery (Figure 4A; difference be-
purposefully chosen to infect neurons sparsely). To testtween 24 hr no drug followed by 24 hr TTX versus 48
if secreted A can indeed act intercellularly, we com-hr no drug, p 0.004, K-S). Similar results were obtained
pared synaptic function onto two uninfected cells (a andfor NMDA responses (data not shown). Thus, preventing
b ); cell a was chosen from a region containing manyneuronal activity for 24 hr can reverse the depression
infected cells, while cell b was chosen from a regionof transmission produced by acute APP overexpression.
with no infected cells (Figures 5A and 5B). The twoOur experiments, however, do not indicate if the effects
uninfected cells were selected to be about 500M apart,of chronic APP overexpression can be reversed.
and a stimulating electrode was placed equidistant to
both cells (see Experimental Procedures). To maximize
A Depresses Transmission in a Noncell- A production, we expressed full-length APPSWE. Excit-
Autonomous Manner atory synaptic responses were recorded simultaneously
We wished to test whether A produced from overex- from cells a and b, and a ratio of the amplitude response
pressing neurons can affect neighboring neurons. The (response of cell a/response of cell b ) was computed.
experiments above show that overexpression of APP Uninfected neurons surrounded by APPSWE had similar
in a neuron can cause synaptic depression onto that baseline electrophysiological properties as neurons
neuron, compared to a control nearby neuron. One inter- from uninfected regions (input resistance: uninfected
pretation of these results is that A acts only on the cell region, 215  15 MOhm (n  7); infected region, 205 
that produces it, that is, in a strictly cell-autonomous 12 MOhm [n14]; p 
 0.6). In accordance with the pre-
manner. An alternative interpretation is that noninfected, diction that A can affect neurons in a noncell-auto-
control neurons in these experiments can be affected nomous manner, uninfected neurons surrounded by
APPSWE-infected neurons had significantly depressedby the secreted A, but they fail to respond because
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transmission when compared to distant control neurons We next considered under what conditions of electri-
cal activity this regulation would be operative when APP(50% reduction in both AMPA- [n  20, p  0.001]
and NMDA- [n 20, p 0.001] mediated synaptic trans- and A are expressed at endogenous levels. As our
previous experiments relied on expression of humanmission; Figure 5C and 5D, inset), suggesting that unin-
fected neurons in infected regions were responding to APP, it was important to determine if rodent A, which
differs from human A at 3 amino acids, produced athe local high concentrations of A. In further support
of this view, responses from an APP-infected neuron in a similar phenotype. This sequence difference has been
suggested to be responsible for the enhanced toxic andheavily infected region were no different from responses
onto a nearby noninfected neuron (AMPA: control: biologically active properties of the human form of the
peptide (Johnstone et al., 1991). Expression of rodent100%  7.8%, infected: 94%  8.1%, n  36, p  0.3;
NMDA: control 100%  12.3%, infected 93%  13.8%, -CTF in neurons was sufficient to depress synaptic
transmission (AMPA: control: 100%  6.2%, infected:n  33, p  0.2; compare with Figure 2B).
To control for effects other than increased production 64.5%  8.0%, [n  30, p  0.001]; NMDA: control
100%  13.4%, infected 73.5%  12.8%; n  23, p of A, we performed a comparable experiment using
the APPMV mutant, described above. Uninfected neurons 0.006). Thus, we conclude that like human A, rodent A
peptides are biologically active and capable of exertingsurrounded by APPMV-infected neurons had similar lev-
els of transmission when compared to distant control electrophysiological effects, despite their inability to
form amyloid pathology in the rodent brain.neurons (as expected, no reduction in either AMPA [n
19, p  0.7] or NMDA [n  19, p  0.6]; Figures 5C and In wild-type animals, acute application of L-685,458
had no effect on basal transmission (45 min after drug,5D, inset). Importantly, the effect by APPSWE on transmis-
sion onto uninfected neurons was significantly different 0.95  0.02 of baseline; 45 min after vehicle, 0.96 
0.02; p  0.8), no effect on long-term depression (LTD)from the effect of APPMV (Figures 5C and 5D). Taken
together, these results indicate that A from neurons (after low-frequency stimulation, vehicle control: 70%
2.5% [n  25], L-685,458: 73%  2.7% (n  26); p overexpressing APP can depress synaptic transmission
onto nearby neurons when sufficient levels of A are 0.4), nor on single-tetanus LTP (Figure 6B). A pairing
protocol (generally considered to be a stronger stimulusachieved.
As a further test of the depressive effects of secreted than a single tetanus) revealed a small (but not signifi-
cant) increase in potentiation in the presence of theA, we bath applied synthetic A (1-40 and 1-42) onto
hippocampal slices. While it is not known what local drug (Figure 6A). This effect became more obvious with
repeated tetanic stimulation, which produced signifi-concentrations can be attained by secreted A, nor what
oligomeric forms render these peptides active, we noted cantly more potentiation in the presence than in the
absence of L-685,458 (Figure 6C). Furthermore, whilea concentration-dependent depression of transmission
(Figure 5E). This is consistent with the view that secreted acute application of L-685,458 produced no detectable
effects on baseline transmission (see above), 24 hr appli-A depresses synaptic transmission.
cation of the drug increased the frequency of miniature
EPSCs in wild-type slices (Figure 6D). These results sug-A as a Negative Feedback Regulator
gest that strong acute electrical activity or low chronicof Neuronal Activity
activity can recruit A-induced synaptic depression inThe data presented above indicate that increased neu-
wild-type tissue. The stronger stimuli and longer periodsronal activity promotes the formation of A and that
required to detect effects of endogenous A is consis-increased A formation depresses synaptic function.
tent with the fact that brain tissue from rats or miceWhile these relationships were obtained primarily with
contain very low steady-state levels of A peptides de-overexpressed human APP, they suggest the existence
rived by processing at the 1 BACE site (De Strooperof a negative feedback process wherein higher levels
et al., 1995).of neuronal activity may increase the production of A
from endogenous APP and lead to synaptic depression
that could curtail excessive activity. We therefore de- Discussion
signed a series of experiments to examine the effects
of different levels of APP expression, and different stim- Activity-Dependent APP Processing
and A Secretionulation conditions, on A-induced synaptic depression.
We first tested the effects of a standard LTP-inducing Our studies have identified a novel regulatory mecha-
nism by which individual neurons or neuronal networksprotocol in the context of APP overexpression. Follow-
ing a pairing protocol (Figure 6A), neurons from organo- may control A production and secretion. Generation
of both A40 and the more fibrillogenic A42 can betypic APPSWE transgenic slices showed a transient poten-
tiation which returned to baseline levels within 25 min controlled by neuronal electrical activity. This occurs in
the context of APP overexpression in either transgenicof LTP induction; potentiation persisted in control neu-
rons for the duration of the experiment (Figure 6A). These (chronic) or virally (acutely) driven settings and also un-
der endogenous levels of APP. These results comple-results are consistent with the view that acute enhance-
ment of synaptic activity (e.g., a pairing protocol) can ment earlier studies indicating that neuronal electrical
activity can modulate generation of APP secretory prod-drive the production of A, which subsequently de-
presses synaptic function and offsets LTP. This view ucts in wild-type tissue (Nitsch et al., 1993). Our studies
are consistent with the notion that neuronal electricalis supported by the finding that when using the same
conditions, bath application of L-685,458 (the -secre- activity modulates APP processing at the -secretase
site. It is now fairly well established that neural activitytase inhibitor) permitted pairing-induced LTP in neurons
from APPSWE slices (Figure 6A). can regulate the trafficking of proteins at synaptic sites
APP Processing and Synaptic Function
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Figure 6. The -Secretase Inhibitor L-685,458
Reveals Stimulus Conditions Recruiting
A-Induced Depression in Wild-Type Hippo-
campal Slices
(A) Whole-cell recordings of neurons from WT
or APPSWE organotypic mouse slices in the
presence or absence of -secretase inhibi-
tion. After a short baseline, LTP was induced
in one pathway by a pairing protocol, while
the other pathway was not paired to monitor
baseline responses. Evoked AMPA-R-medi-
ated synaptic responses from the paired path-
way (top) and control pathways (bottom). Leg-
end: open diamonds: WT slices, DMSO treated;
filled triangles: Tg slices, DMSO treated; filled
squares: WT slices, L-685,458 treated; open
circles: Tg slices, L-685,458 treated. Inset:
sample traces of AMPA-R mediated synaptic
transmission before (thin) and after (thick)
whole-cell pairing protocol.
(B) Field recordings of evoked EPSPs moni-
tored from acute rat slices exposed (open
symbols, n  23) or not exposed (filled sym-
bols, n  26) to 1 M L-685,458. At arrow,
tetanic stimulation (1 s, 100 Hz) was de-
livered.
(C) Same as (A) except ten tetanic stimuli
were delivered, each tetanus (arrow) sepa-
rated by 3 min. Responses following ten te-
tanic stimuli were significantly different, p 
0.03 (control n  17; treated n  17). Scale
bars: 200V, 10 ms.
(D) Miniature EPSC responses recorded in
whole-cell mode from neurons in wild-type
organotypic slices maintained in the absence
(control, n  22) or presence of 1 M
L-685,458 (n  18). Frequency of events was
enhanced (control: 0.47 0.03 Hz; L-685,458:
0.75  0.9 Hz) with no change in their mean
amplitude (control: 11.8  0.5 pA; L-685,458:
11.9 0.9 pA) by drug treatment. Right, sam-
ple traces for each condition.
(e.g., AMPA-Rs [Carroll et al., 2001; Malinow et al., lieved that A accumulation in the brain is a critical
component. While A can be neurotoxic (Yankner et al.,2000]), and hence, it is possible that neuronal activity
promotes the endocytosis of surface APP, enhancing 1990), there is growing evidence that cognitive decline
can occur before, or independent of, neuronal loss, asthe accessibility of APP to BACE in endosomal/recycling
compartments. amyloid-dependent physiological and behavioral defi-
cits in transgenic mice can occur in the absence of cellIt is of interest, and potential clinical relevance, that
inhibiting excitatory synaptic transmission or blocking death (Hsiao et al., 1996; Morgan et al., 2000; Westerman
et al., 2002). Here, we show that processing of overex-NMDA-Rs prevents the synaptic depressive effects of
APP overexpression. Our results are consistent with the pressed APP into A leads to depression of synaptic
transmission. This result is consistent with previousfindings of two clinical studies. First, the benzodiaze-
pines, agents that enhance inhibitory transmission and studies of transgenic mice expressing APP harboring
mutations known to cause early onset familial Alzhei-thereby decrease excitatory drive, have been found to
protect against Alzheimer’s disease (Fastbom et al., mer’s disease (Fitzjohn et al., 2001; Hsia et al., 1999).
Such mice produce more A and show depressed syn-1998). This observation is notable in view of our findings
that benzodiazepines reduce secretion of A peptides aptic function before amyloid plaque deposition be-
comes evident. Our molecular dissection of the APPfrom hippocampal slice neurons (Figure 1B). Second,
NMDA receptor antagonists block the APP-induced syn- molecule reveals that A is responsible for this synaptic
depression. Such effects could contribute to the cogni-aptic depression in our studies, and NMDA-R antago-
nists have been shown to be effective in slowing cogni- tive dysfunction in AD (Selkoe, 2002; Walsh et al., 2002).
tive decline in mild to severe AD patients (Reisberg et
al., 2000; Winblad and Poritis, 1999). A Normal Physiologic Role for A?
While our results are consistent with the notion that
high A levels may disrupt synaptic function, our dataA Disrupts Neuronal Transmission: a Mechanism
for the Early Cognitive Defects of AD? suggest that A may also have a normal negative feed-
back function. Increased neuronal activity producesThe mechanisms responsible for the cognitive decline
underlying AD are not understood, but it is widely be- more A; the enhanced Aproduction depresses synap-
Neuron
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2000). Full-length APP constructs contain the 12 amino acid myc
sequence immediately before the termination codon. APPMV was
generated using the Quick Change Mutagenesis Kit (Stratagene).
Constructs were cloned into pSinRep5 shuttle vector and infective
sindbis pseudoviruses were generated as described (Malinow et al.,
1999).
Hippocampal Slices
Organotypic hippocampal slices were prepared from 6-day-old rat
or APPSWE transgenic mice (Borchelt et al., 1996) and maintained
using standard methods (Stoppini et al., 1991). Four slices were
placed on each membrane. To measure A secretion from culturedFigure 7. Negative Feedback Model Indicating Proposed Interac-
transgenic mouse slices, slices were maintained with or withouttion between Neural Activity and APP Processing
drugs for 4 days before samples were collected for measurements.Neural activity regulates -secretase actions on APP. Formation of
Individual values represent pooling media from the subsequent 9A depresses synaptic transmission. Synaptic depression de-
days. A was measured using a two-site ELISAs that specificallycreases neural activity.
detect the C terminus of A, as previously described (Tomita et al.,
1997). For transient APP overexpression studies, A was measured
from media of infected slices 24 hr after infection. For whole-celltic function; the depressed synaptic function will de-
electrophysiology, slices were allowed to express recombinant pro-crease neuronal activity (Figure 7A) . Examples of synap-
tein for 24 hr after infection, unless indicated otherwise. Slicestic homeostasis have recently been reported (Davis et
were then transferred to a recording chamber and perfused with
al., 1998; Turrigiano et al., 1998), as well as intercellular solution (22C–25C) containing 119 mM NaCl, 2.5 mM KCl, 4 mM
depression following strong tetanic stimulation (Scanzi- CaCl2, 4 mM MgCl2, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM glucose,
and 0.002 mM 2-chloroadenosine, at pH 7.4 and gassed with 5%ani et al., 1996), although the signaling molecules medi-
CO2/95% O2. 100 M picrotoxin was included in the bath whenating these processes have not been identified. In sup-
measuring AMPA or NMDA responses; 20 M NBQX and 100 Mport of this model, we find that in addition to human A,
D,L AP5 were added instead of picrotoxin in experiments measuringrodent A can also depress synaptic transmission. This
inhibitory currents. 2-chloroadenosine was included to prevent
is important because rodent A is believed not to have bursting. Patch recording pipettes (3–6 M) were filled with intracel-
amyloidogenic properties. We find that in wild-type rat lular solutions containing 115 mM cesium methanesulfonate, 20 mM
CsCl, 10 mM HEPES, 2.5 mM MgCl2, 4 mM Na2ATP, 0.4 mM Na3GTP,tissue, multiple tetani lead to greater synaptic poten-
10 mM sodium phosphocreatine, and 0.6 mM EGTA, at pH 7.25.tiation in the presence of the -secretase inhibitor
Whole-cell recordings were obtained simultaneously from two post-L-685,458. This suggests that multiple tetani drive APP
synaptic CA1 neurons (typically one infected expressing GFP), andprocessing, producing a synaptic depression (in addi-
signals were amplified with Axopatch-1D amplifiers (Axon Instru-
tion to LTP) that can be revealed by -secretase inhibi- ments). Synaptic responses were evoked by one or two bipolar
tion. This phenomenon is seen when multiple tetani are electrodes with single voltage pulses (200 s, less than 20V). The
stimulating electrodes were placed over Schaffer collateral fibersdelivered suggesting that the negative feedback system
300–500m from the recorded CA1 cells. Stimulus level was set tomediated by APP processing may normally only be rap-
produce a synaptic response of40 pA in the control cell. Synapticidly recruited under very high activity levels. This may
responses at 	60mV, 0mV, and 40mV were averaged over 50–100explain the enhanced kainate-induced seizure activity
trials. AMPA receptor-mediated response was measured by averag-
in APP knockout mice (Steinbach et al., 1998). We also ing a 5 ms window about the peak response at 	60mV; GABA
find that 24 hr application of -secretase inhibitor receptor-mediated response was measured by averaging a 5 ms
window about the peak response at 0mV. NMDA receptor-mediatedL-685,458 leads to enhanced synaptic transmission (in-
response was measured by averaging a 10 ms window 150 mscreased miniature EPSC frequency, Figure 6D). The ab-
after the stimulus artifact of responses recorded at 40mV. Forsence of an overt phenotype in mice lacking BACE (Cai
experiments measuring synaptic responses from distant uninfectedet al., 2001; Luo et al., 2001) or APP (Zheng et al., 1996)
cell pairs at positions [0,0] and [x,y], the stimulation electrode was
suggests that other mechanisms can compensate for placed at a site [x,y] equidistant for the two cells and a distance
this in these mice. (300m) from the cell body layer using a simple quadratic formula.
Coordinates were obtained using a Mitutoyo digital micrometer con-How could disturbances in this proposed negative
trolling stage position. Miniature EPSC events were recorded in thefeedback loop contribute to AD? One can envision a
presence of 1 m TTX (no adenosine) and analyzed using the Mini-number of scenarios. For instance, if synapses lose sen-
Analysis software (Synaptosoft). At least 200 events were obtainedsitivity to A-induced depression, persistently elevated
from each cell. Paired pulse facilitation was elicited by using an
neuronal activity may go unchecked. High levels of neu- interstimulus interval of 50 ms. For whole-cell LTP experiments,
ronal activity could lead to excitotoxicity (Zoghbi et al., potentiation was induced by pairing 2 Hz stimulation with depolar-
ization of the postsynaptic neuron to 0mV for 120 s; recordings were2000), as well as higher levels of secreted A peptides,
maintained for at least 35 min after pairing. The EPSC amplitudewhich may in turn form neurotoxic fibrils that eventually
after pairing was normalized to the average amplitude of 20–30kill neurons (Cotman et al., 1992; Lambert et al., 1998;
sweeps before pairing. For field potential experiments, hippocampalWalsh et al., 1999; Yankner et al., 1990). Alternatively, A
slices were prepared from P14–P21 animals. Slices were preincu-
production may become constitutive (loose sensitivity to bated for 1 hr in drug (1 M L-685,458) or vehicle (0.1% DMSO) and
synaptic activity), with resulting synaptic depression placed in a recording chamber containing solution indicated above
(no 2-chloroadenosine). Responses were evoked by alternatingand neuronal toxicity.
stimuli through two bipolar stimulating electrodes (1V–10V, 200 s)
and recorded with glass electrodes placed in CA1 s. radiatum andExperimental Procedures
amplified with Cyberamp 320 (Axon Instruments). Responses from
four slices were recorded simultaneously; drug and no drug experi-Construction of Plasmids and Pseudoviruses
APP695 (human) and GFP (Clonetech) were coexpressed by using ments were interleaved. All results are reported as mean SEM, and
statistical significance was set at p  0.05. Statistical differences ofan internal ribosomal entry site (IRES) construct (Hayashi et al.,
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the means were determined using Wilcoxon for paired measure- aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2,
271–276.ments and t test for nonpaired measurements. To compare the
effects on transmission produced by two different APP constructs, Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y.,
a cumulative distribution of response ratios (response in infected Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D.J. (1992).
cell/response in control cell) were generated for each construct. The Mutation of the beta-amyloid precursor protein in familial Alzhei-
Kolmogorov-Smirnov (K-S) test was used to determine statistically mer’s disease increases beta-protein production. Nature 360,
significant differences between the two cumulative distributions. 672–674.
Citron, M., Teplow, D.B., and Selkoe, D.J. (1995). Generation of
Immunoblot Analysis
amyloid beta protein from its precursor is sequence specific. Neuron
Organotypic slices from APPSWE transgenic mice or wild-type rats 14, 661–670.
were solubilized, and extracts were prepared for Western blot analy-
Cotman, C.W., Pike, C.J., and Copani, A. (1992). Beta-amyloid neu-sis (Sisodia et al., 1993). APP fragments were identified by the cyto-
rotoxicity: a discussion of in vitro findings. Neurobiol. Aging 13,plasmic terminus antibody CT15, which recognizes full-length APP
587–590.as well as CTFs, or the -cleavage site-specific antibody 3D6 (Bac-
skai et al., 2001). Secreted APPs measurements were carried out Cullen, W.K., Suh, Y.H., Anwyl, R., and Rowan, M.J. (1997). Block
by immunoprecipitating APPs from 500  of culture media using of LTP in rat hippocampus in vivo by beta-amyloid precursor protein
antibody 54, which specifically recognizes the C terminus of APPSWEs fragments. Neuroreport 8, 3213–3217.
(Howland et al., 1998), and subsequently blotting using antibody Davis, G.W., DiAntonio, A., Petersen, S.A., and Goodman, C.S.
22C11, which recognizes the N terminus of APP. Quantifications of (1998). Postsynaptic PKA controls quantal size and reveals a retro-
immunoblots were done by enhanced chemiluminescence (ECL; grade signal that regulates presynaptic transmitter release in Dro-
NEN) and densitometric scanning of the films under linear exposure sophila. Neuron 20, 305–315.
conditions.
De Strooper, B., Simons, M., Multhaup, G., Van Leuven, F., Bey-
reuther, K., and Dotti, C.G. (1995). Production of intracellular amy-Immunohistochemistry/Imaging
loid-containing fragments in hippocampal neurons expressing humanImmunohistochemistry was performed on organotypic slices after
amyloid precursor protein and protection against amyloidogenesis by1–2 days of infection with the wild-type APP IRES construct that
subtle amino acid substitutions in the rodent sequence. EMBO J. 14,contained a c-tail myc tag. Tissue was fixed in 4% paraformaldehyde
4932–4938.solution overnight at 4C and blocked in PBS containing 10% horse
Fastbom, J., Forsell, Y., and Winblad, B. (1998). Benzodiazepinesserum, 0.2% sodium azide, and 0.1% triton overnight at 4C. Slices
may have protective effects against Alzheimer disease. Alzheimerwere incubated in anti-c-Myc (Calbiochem) in blocking buffer over-
Dis. Assoc. Disord. 12, 14–17.night at 4C. Following a 2 hr room-temperature incubation with a
biotin-conjugated secondary antibody, avidin-Texas red was added Fezoui, Y., Hartley, D.M., Harper, J.D., Khurana, R., Walsh, D.M.,
for 2 hr at room temperature. Immunohistochemistry was imaged Condron, M.M., Selkoe, D.J., Lansbury, P.T., Jr., Fink, A.L., and
using a custom built two-photon laser scanning microscope. Teplow, D.B. (2000). An improved method of preparing the amyloid
beta-protein for fibrillogenesis and neurotoxicity experiments. Amy-
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